The Apple Watch was able to detect irregular heart pulse rates that could signal the need for further monitoring for a serious heart rhythm problem, according to data from a large study funded by Apple Inc, demonstrating a potential future role for wearable consumer technology in healthcare. | Video
The U.S. Food and Drug Administration (FDA) on Wednesday released formal plans to curb the sale of flavored e-cigarettes and slow a surge in teenage use of the popular nicotine devices.
(Reuters Health) - The old adage that drinking beer before wine prevents hangovers turns out to be a myth, German researchers say.
Vertex Pharmaceuticals Inc on Wednesday said its triple-combination treatment for cystic fibrosis led to significant lung function improvement in two late-stage studies, paving the way for a therapy that could eventually address 90 percent of people with the life-shortening genetic condition.
Drugmaker Eli Lilly announced plans on Monday to sell a half-price version of its popular insulin injection Humalog, as it fends off criticism about rising drug prices in the United States.
Sarepta Therapeutics Inc beefed up its gene therapies portfolio through the purchase of its partner Myonexus Therapeutics Inc and reported positive data for a genetic disorder therapy from the privately held company, sending its shares up 9 percent on Wednesday.
(Reuters Health) - Health conditions related to heat are sharply rising and may affect ethnic populations disproportionately, California statistics suggest.
General Electric said on Monday it would sell its biopharma business to Danaher Corp for $21.4 billion (16.3 billion pounds) in the biggest strategy reversal since Lawrence Culp took over as the industrial conglomerate's chief executive in September. | Video
(Reuters Health) - Two chemicals commonly used as e-cigarette flavors might harm users' airway passages, a small experiment suggests.